Chemomab Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
TEL AVIV, Israel, Nov. 12, 2021 /PRNewswire/ — Chemomab Therapeutics, Ltd. (Nasdaq: CMMB) (Chemomab), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced…
Comments Off on Chemomab Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Corporate Update